Skip to main content

Table 1 Baseline subject characteristics

From: Multiparametric cardiovascular magnetic resonance surveillance of acute cardiac allograft rejection and characterisation of transplantation-associated myocardial injury: a pilot study

  Transplant patients (n = 22) Healthy volunteers (n = 10) p value
Male 17 (77%) 7 (70%) 0.660
Age (years) 49 ± 10 49 ± 8 0.961
Non-white 2 (9%) 1 (10%) 0.676
BSA (m2) 1.86 ± 0.20 1.94 ± 0.19 0.290
BMI (kg/m2) 24.7 ± 3.6 25.7 ± 4.1 0.484
eGFR (mL/min/m2) 61 ± 24 89 ± 13 <0.001
HR (bpm) 89 ± 15 60 ± 6 <0.001
Systolic BP (mmHg) 135 ± 17 111 ± 8 <0.001
Indication for transplant    
 DCM 12 (55%) -  
 IHD 6 (27%) -  
 ARVC 2 (9%) -  
 HCM 1 (5%) -  
 Re-transplant 1 (5%) -  
Pregnancy prior to transplantation 3 (14%) -  
VAD prior to transplantation 1 (5%) -  
Donor age (years) 42 ± 7 -  
Donor male 17 (77%) -  
Donor: recipient gender match 18 (82%) -  
Donor cause of death    
 ICH 13 (59%) -  
 Head trauma 5 (23%) -  
 Other 4 (18%) -  
CMV donor pos., recipient neg. 5 (23%) -  
Ischaemic time (min) 184 ± 52 -  
Induction immunosuppression    
 rATG 21 (95%) -  
 Basiliximab 1 (5%) -  
Initial immunosuppression regime    
 Cyclosporine/prednisolone/MMF 21 (95%) -  
 Tacrolimus/prednisolone/MMF 1 (5%) -  
ICU stay (days) 17 ± 19 -  
Hospital stay (days) 36 ± 23 -  
  1. BSA indicates body surface area; BMI body mass index; eGFR estimated glomerular filtration rate; HR heart rate; BP blood pressure; DCM indicates dilated cardiomyopathy; IHD ischemic heart disease; ARVC arrhythmogenic right ventricular cardiomyopathy; HCM hypertrophic cardiomyopathy; (Re-transplant: this patient suffered immediate graft failure and therefore underwent a second transplantation); VAD ventricular assist device; ICH spontaneous intracranial haemorrhage; CMV cytomegalovirus; rATG rabbit antithymocyte globulin; MMF Mycophenolate mofetil; ICU intensive care unit.